Neuroglee Therapeutics develops personalized, evidence-based virtual care solutions to treat and manage patients with neurological conditions. Neuroglee’s adaptive learning platform leverages machine learning to dynamically personalize and optimize treatment based on patients’ unique needs. By combining best-in-class cognitive rehabilitation strategies and virtual care management delivered by an experienced, interdisciplinary clinical team, Neuroglee improves patient outcomes, reduces caregiver and clinician burden, and enhances the overall patient experience. Neuroglee also offers a digital therapeutic candidate, NG-001, which may be used as a stand-alone therapy or combined with pharmacotherapy to empower people living with MCI to obtain the highest quality care for preserving cognition and promoting independence. For more information, visit neuroglee.com